Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Revenue increased by double digits in all 4 businesses. On the earnings side, results benefited from the effects of increased production at the head office plant, higher profit accompanying the increase in revenue, some research and development plans not being carried out, improved foreign exchange gains and losses, and the elimination of the impact of prior-period corporate taxes recorded in the previous year. Meanwhile, the gross profit margin declined due to an increase in unrealized profit and the impact of US tariffs.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥22,488 million (YoY +21.3%) |
| Operating profit | ¥4,675 million (YoY +39.1%) |
| Ordinary income | ¥5,548 million (YoY +111.2%) |
| Profit attributable to owners of the parent | ¥3,980 million (YoY +803.9%) |
| Net income per share | ¥47.93 |
| Equity ratio | End of the current fiscal period 70 / End of previous period 71 |
| Total assets | ¥165,775 million |
| Net assets | ¥116,401 million |
| Full-year earnings forecast | Net Sales ¥90,185 million (YoY +11.1%) / Operating profit ¥16,215 million (YoY +15.1%) / Ordinary income ¥16,091 million (YoY -5.0%) / Net income ¥11,193 million |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | ¥54 → ¥60 |
| Segment revenue | Dental business ¥13,199.99 million (YoY +16.6%), DCI business ¥5,832.34 million (YoY +28.3%), Surgical Business ¥1,596.05 million (YoY +37.1%), Machinery and Engineering ¥1,860.35 million (YoY +23.4%) |
| Segment profit | Dental business (segment operating income) ¥4,403.03 million (YoY +13.9%), DCI business (segment operating income) ¥193.98 million, Surgical business (segment operating income) ¥781.92 million (YoY +42.1%), Machinery business (segment operating income) ¥469.91 million (YoY +620.9%) |
| Depreciation and amortization | ¥1,037,208 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on Disposal of Fixed Assets ¥820 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Material subsequent events | On 1 April 2026, consolidated subsidiary NSK America Corp. acquired all shares of Acra Cut, Inc. and Intech, Inc., making them subsidiaries. The acquisition consideration was ¥12,268,546 thousand for Acra Cut and ¥1,672,983 thousand for Intech, while acquisition-related expenses were ¥103,106 thousand. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (no eligible attendees) |
| Issued Shares at Period-End | 92,218,200 shares |
| Treasury Shares at Period-End | 9,173,418 shares |
| Factors Behind Changes in Business Performance | Revenue increased by double digits in all 4 businesses. On the earnings side, results benefited from the effects of increased production at the head office plant, higher profit accompanying the increase in revenue, some research and development plans not being carried out, improved foreign exchange gains and losses, and the elimination of the impact of prior-period corporate taxes recorded in the previous year. Meanwhile, the gross profit margin declined due to an increase in unrealized profit and the impact of US tariffs. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased by double digits in all four businesses: Dental, DCI, Surgical and Machinery. On the earnings side, the effects of increased production at the head office plant, higher profit accompanying the increase in revenue, and some research and development plans not being carried out, together with improved foreign exchange gains and losses and the elimination of the impact of prior-period corporate taxes recorded in the previous year, contributed to results. Meanwhile, the gross profit margin declined due to an increase in unrealized profit and the impact of US tariffs.